| __timestamp | Agios Pharmaceuticals, Inc. | Incyte Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 100371000 | 347523000 |
| Thursday, January 1, 2015 | 141827000 | 479514000 |
| Friday, January 1, 2016 | 220163000 | 581861000 |
| Sunday, January 1, 2017 | 292681000 | 1326361000 |
| Monday, January 1, 2018 | 341324000 | 1197957000 |
| Tuesday, January 1, 2019 | 410894000 | 1154111000 |
| Wednesday, January 1, 2020 | 367470000 | 2215942000 |
| Friday, January 1, 2021 | 256973000 | 1458179000 |
| Saturday, January 1, 2022 | 279910000 | 1585936000 |
| Sunday, January 1, 2023 | 288903000 | 1627594000 |
| Monday, January 1, 2024 | 301286000 | 2606848000 |
Infusing magic into the data realm
In the competitive world of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Incyte Corporation and Agios Pharmaceuticals, Inc. have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Incyte consistently outpaced Agios, with its R&D expenses peaking at approximately $1.63 billion in 2023, a staggering 370% increase from 2014. In contrast, Agios's R&D spending grew by about 188% over the same period, reaching nearly $289 million in 2023.
This divergence highlights Incyte's aggressive pursuit of new therapies, while Agios maintains a more measured approach. The data underscores the importance of strategic R&D investments in driving innovation and maintaining a competitive edge in the biotech industry.
Analyzing R&D Budgets: Teva Pharmaceutical Industries Limited vs Agios Pharmaceuticals, Inc.
Analyzing R&D Budgets: Biogen Inc. vs Agios Pharmaceuticals, Inc.
BeiGene, Ltd. vs Incyte Corporation: Strategic Focus on R&D Spending
Comparing Innovation Spending: Incyte Corporation and Viatris Inc.
R&D Insights: How Incyte Corporation and Amneal Pharmaceuticals, Inc. Allocate Funds
R&D Spending Showdown: Incyte Corporation vs Protagonist Therapeutics, Inc.
Incyte Corporation vs Soleno Therapeutics, Inc.: Strategic Focus on R&D Spending
Incyte Corporation or Vericel Corporation: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Incyte Corporation and Geron Corporation
Who Prioritizes Innovation? R&D Spending Compared for Incyte Corporation and BioCryst Pharmaceuticals, Inc.
Sarepta Therapeutics, Inc. or Agios Pharmaceuticals, Inc.: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Apellis Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc.